Why Social Health Matters for Treatment Initiation and Persistence
Pharmaceutical companies have invested heavily in patient support programs focused on access, affordability, education, and treatment navigation. Yet across therapeutic areas, many patients still never initiate treatment or discontinue therapy too early. Traditional patient support programs are highly effective at addressing transactional barriers, but many behavioral barriers remain largely unaddressed.
This whitepaper from Wisdo Health explores how social health, peer support, and shared lived experience influence patient behavior, medication adherence, treatment persistence, and real-world outcomes. Research shows that individuals with low social support face a significantly higher risk of medication non-adherence, highlighting the important role emotional connection and peer reinforcement play throughout the treatment journey.
The paper outlines why emotional isolation and lack of meaningful support continue to impact patient engagement, and how structured peer connection can complement traditional patient support strategies. It also explores how pharmaceutical companies can strengthen treatment initiation, persistence, and long-term adherence by addressing the behavioral gaps that often prevent patients from staying engaged in care.
Download the whitepaper to learn why social health may become an essential component of modern patient engagement and adherence strategy.
Read the white paper at: https://resources.wisdo.com/wp-content/uploads/2026/04/TheSocialHealthOpportunity_Wisdo_041426.pdf
